Paolo Fundaro, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 325 shares at $232.00 ($75K) on 2014-05-09, disclosed to the SEC on 2014-05-09.
Scheduled sale ($75k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2019-03-29 | $467K | — | Filing → |
| ICPT | SELL | 2015-07-24 | $166K | — | Filing → |
| ICPT | SELL | 2014-08-12 | $78K | — | Filing → |